In the U.S. the vaccine had an effectiveness of 72% but that number dropped to just 57% in South Africa where a more infectious variant of the virus is spreading.
Johnson & Johnson’s Single-Dose Covid-19 Vaccine Is 66% Effective In Global Trial, But Has Lower Efficacy Against South African Variant
